Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

59.44
Delayed Data
As of Jul 30
 +0.41 / +0.69%
Today’s Change
33.51
Today|||52-Week Range
72.44
+38.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$2.1B

Company Description

Lannett Co., Inc. develops, manufactures, markets and distributes generic versions of pharmaceutical products. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. The company was founded in 1942 and is headquartered in Philadelphia, PA.

Contact Information

Lannett Co., Inc.
9000 State Road
Philadelphia Pennsylvania 19136
P:(215) 333-9000
Investor Relations:

Employees

Shareholders

Mutual fund holders38.93%
Individual stakeholders31.62%
Other institutional27.08%

Top Executives

Arthur P. BedrosianCEO, Director & Head-Investor Relations
Michael J. BogdaPresident
William F. SchreckChief Operating Officer
Martin P. GalvanChief Financial Officer, Treasurer & VP
Robert EhlingerChief Information Officer & VP-logistics